The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice

• Main Authors: Laura Nickel (Author), Annika Sünderhauf (Author), Elias Rawish (Author), Ines Stölting (Author), Stefanie Derer (Author), Christoph Thorns (Author), Urte Matschl (Author), Alaa Othman (Author), Christian Sina (Author), Walter Raasch (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The angiotensin II (type 1) (AT1) receptor blocker telmisartan (TEL) is beneficial for the treatment of individuals suffering from metabolic syndrome. As we have shown that TEL has an impact on gut microbiota, we investigated here whether TEL influences gut barrier function. C57BL/6N mice were fed w...